Response to comment by Moxon et al

Clin Sci (Lond). 2018 Jan 2;132(1):39-41. doi: 10.1042/CS20171555. Print 2018 Jan 16.

Authors

Dawn Thompson¹, Nicola Morrice², Louise Grant², Samantha Le Sommer², Emma K Lees², Nimesh Mody², Heather M Wilson², Mirela Delibegovic¹

Affiliations

¹ Institute of medical sciences, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, U.K. m.delibegovic@abdn.ac.uk dthompson@abdn.ac.uk.
² Institute of medical sciences, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, U.K.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Atherosclerosis
Diabetes Mellitus, Type 2
Disease Models, Animal
Mice
Plaque, Atherosclerotic*
Protein Tyrosine Phosphatase, Non-Receptor Type 1*

Substances

Protein Tyrosine Phosphatase, Non-Receptor Type 1